IRIS
FARINA, DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.742
EU - Europa 1.463
AS - Asia 1.063
SA - Sud America 117
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 4.401
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.727
CN - Cina 462
SG - Singapore 315
UA - Ucraina 255
IE - Irlanda 254
GB - Regno Unito 183
TR - Turchia 179
SE - Svezia 169
DE - Germania 156
FR - Francia 153
IT - Italia 129
BR - Brasile 107
FI - Finlandia 78
IN - India 63
RU - Federazione Russa 42
CZ - Repubblica Ceca 16
IR - Iran 10
CA - Canada 8
HK - Hong Kong 7
CH - Svizzera 6
MX - Messico 6
ZA - Sudafrica 6
BE - Belgio 5
EU - Europa 5
AR - Argentina 4
BD - Bangladesh 4
PL - Polonia 4
RS - Serbia 3
VN - Vietnam 3
BG - Bulgaria 2
EG - Egitto 2
GR - Grecia 2
IQ - Iraq 2
JO - Giordania 2
KR - Corea 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
SA - Arabia Saudita 2
AT - Austria 1
AU - Australia 1
CL - Cile 1
CR - Costa Rica 1
EC - Ecuador 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
MD - Moldavia 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.401
Salva come PNG Salva come JPEG
Città #
Chandler 323
Jacksonville 307
Dublin 253
Singapore 250
Southend 152
Beijing 128
Princeton 108
The Dalles 100
Izmir 92
Nanjing 89
Ashburn 75
Dearborn 58
Wilmington 58
Munich 54
Cambridge 49
Santa Clara 38
Altamura 37
Tongling 36
New York 35
Nanchang 33
Ann Arbor 28
Shenyang 21
Chieti 16
Turku 15
Washington 15
Hebei 14
Jiaxing 14
Kunming 14
Los Angeles 14
Tianjin 14
Boardman 13
Hangzhou 13
Helsinki 13
Woodbridge 13
Brno 12
Changsha 12
Grevenbroich 12
Jinan 11
Frankfurt am Main 10
Norwalk 10
Guangzhou 9
Ardabil 8
Augusta 8
Monmouth Junction 8
São Paulo 8
Camerino 7
Council Bluffs 7
Dallas 7
Hong Kong 7
San Mateo 7
Boston 6
Campobasso 6
Fribourg 6
Houston 6
Lanzhou 6
San Francisco 6
Brussels 5
Leawood 5
Ningbo 5
Changchun 4
Chicago 4
Curitiba 4
Hefei 4
Johannesburg 4
London 4
Montesilvano Marina 4
Montreal 4
Olomouc 4
Phoenix 4
Taizhou 4
Teramo 4
Ankara 3
Belgrade 3
Belo Horizonte 3
Istanbul 3
Joinville 3
Manchester 3
Mexico City 3
Moscow 3
Mumbai 3
Nuremberg 3
Orange 3
Porto Alegre 3
Rio de Janeiro 3
San Vito Chietino 3
Tappahannock 3
Torino 3
Torre de' Passeri 3
Warsaw 3
Zhengzhou 3
Amman 2
Atlanta 2
Bexley 2
Bologna 2
Brasília 2
Brooklyn 2
Cairo 2
Campinas 2
Campo Grande 2
Charlotte 2
Totale 2.811
Salva come PNG Salva come JPEG
Nome #
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 113
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 113
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 111
Increasing age at disability milestones among MS patients in the MSBase Registry 111
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 107
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 102
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 102
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 101
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 99
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 99
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 97
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 95
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 94
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 94
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 94
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 94
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 94
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 94
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 93
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 93
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 93
Interferone beta: effetti collaterali 88
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 88
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 86
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 86
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 85
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 84
JCV-Ab serostatus in MS patients treated with Natalizumab 84
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 84
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 82
Natalizumab-associated PML-IRIS: the Chieti experience. 81
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 79
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 79
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 78
Autologous HSCT for severe progressive Multiple Sclerosis in a multicenter trial: impact on disease activity and quality of life 77
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 77
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 76
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. 76
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 75
Lymphomononuclear cells from multiple scerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. 74
Interferone beta1b: bilancio su un gruppo di 30 pazienti 72
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 72
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study 72
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 71
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 70
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 70
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 68
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 64
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 59
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 58
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 57
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis 54
Long-term efficacy and tolerability of natalizumab treatment in multiple sclerosis patients: a multicentre experience in Italy 46
Totale 4.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.728
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 2 58 0 17 63 2 3 34 29 47 10
2021/2022213 1 4 6 49 6 2 6 19 12 3 31 74
2022/2023806 58 122 45 83 86 164 40 56 108 6 23 15
2023/2024397 34 18 25 6 29 164 72 3 1 7 2 36
2024/2025893 60 99 111 13 13 31 19 31 62 43 197 214
2025/2026230 191 39 0 0 0 0 0 0 0 0 0 0
Totale 4.465